iSpecimen (ISPC) Free Cash Flow (2020 - 2026)

iSpecimen's Free Cash Flow history runs 7 years deep, the most recent figure standing at -$4.1 million for Q1 2026.

• In Q1 2026, Free Cash Flow fell 270.66% year-over-year to -$4.1 million; the TTM figure through Mar 2026 stood at -$8.2 million (down 12.27% YoY), while the FY2025 annual figure was -$5.2 million, up 36.82% from the prior year.
• Free Cash Flow was -$4.1 million for Q1 2026 at iSpecimen, down from -$916923.0 in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of -$167540.0 in Q2 2023 to a low of -$4.4 million in Q1 2023.
• Historically, Free Cash Flow has averaged -$2.1 million across 5 years, with a median of -$1.7 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Free Cash Flow surged 93.07% in 2023, then plunged 818.74% in 2024.
• A 5-year view of Free Cash Flow shows it stood at -$1.6 million in 2022, then sank by 108.28% to -$3.4 million in 2023, then dropped by 5.23% to -$3.6 million in 2024, then soared by 74.39% to -$916923.0 in 2025, then tumbled by 342.99% to -$4.1 million in 2026.
• The last three Free Cash Flow figures came in at -$4.1 million (Q1 2026), -$916923.0 (Q4 2025), and -$3.0 million (Q3 2025), per Business Quant data.